Physical activity (PA) is essential for the cardiovascular, emotional, and social health of all children and adolescents.

BACKGROUND: Massive left ventricular hypertrophy (LVH) is a risk factor for sudden cardiac death in children with hypertrophic cardiomyopathy (HCM), but little is understood about its natural history.

BACKGROUND: Identifying and addressing barriers to antihypertensive medication adherence is critical for hypertension control ...

BACKGROUND: Genetic variants in components or regulators of the RAS-MAPK signaling pathway are causative for severe and early-onset hypertrophic cardiomyopathy (HCM) in patients with Noonan syndrome ...

CM uniquely uses hands-on instruction to facilitate knowledge transfer, offering a unique opportunity for patients with ...

The American Heart Association (AHA) Science Advisory, “Dietary Protein and Weight Reduction: A Statement for Healthcare Professionals From the Nutrition Committee of the Council on Nutrition, ...

Disturbance in protein synthesis and degradation plays a crucial role in various biological and pathological processes. E3 ubiquitin ligase substrate–binding adaptor SPOP (speckle-type POZ [poxvirus ...

Cardiovascular disease (CVD), including coronary artery disease, heart failure, arrhythmias, and stroke, is the leading cause of morbidity and mortality in the United States, and accounts for >$400 ...

Part 6: Electrical Therapies Automated External Defibrillators, Defibrillation, Cardioversion, and Pacing2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency ...

Background and Purpose—There is currently no consensus on (1) the percentage of patients who develop spasticity after ischemic stroke, (2) the relation between spasticity and initial clinical findings ...

Warfarin (brand names Coumadin and Jantoven) is a prescription medication used to prevent harmful blood clots from forming or growing larger. Beneficial blood clots prevent or stop bleeding, but ...

In the article by Jones et al, “Can We End the Salt Wars With a Randomized Clinical Trial in a Controlled Environment?” which published online on July 2, 2018, and appeared in the July 2018 issue of ...